SORAFENIB

Clinical trials for SORAFENIB explained in plain language.

Never miss a new study

Get alerted when new SORAFENIB trials appear

Sign up with your email to follow new studies for SORAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for AML patients: study tests better drug to keep leukemia away after transplant

Disease control Recruiting now

This study tests whether a newer drug, gilteritinib, works better than the current standard, sorafenib, to prevent leukemia from coming back after a stem cell transplant. About 594 adults and teens with a specific genetic mutation (FLT3-ITD) will be randomly assigned to take one …

Matched conditions: SORAFENIB

Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated May 26, 2026 09:00 UTC

SORAFENIB

Get alerted when new SORAFENIB trials appear

New hope for AML patients: study tests better drug to keep leukemia away after transplant